Hospital Ranking Systems Can Be Misleading for Orthopedic Care: Subject to Misrepresentation That Can Lead to Frustration That May Confuse Patients

September 1, 2020

Hospital Ranking Systems: In the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) this month, a new study investigated five hospital rating systems to assess consistency and agreement among the hospitals deemed “high-performing” and “low-performing” for orthopedic surgery. It revealed that the systems generally rate hospitals based on varied data sources and different methodologies that lack robust formal validation. Thus, they are subject to a misrepresentation that can lead to alienated, frustrated, and confused patients.

“Hospital ranking systems are valuable consumer tools for information on the safety and quality of our nation’s hospitals,” said lead author and Vice-Chair of the Department of Orthopaedics at Northwestern Medicine, David W. Manning, MD, FAAOS. “However, our research found there to be very little consistency between rating systems specific to the orthopedic specialty. In fact, it was more likely that any given hospital would be rated as both ‘high-performing’ and ‘low-performing’ for quality across multiple rating systems than it was for anyone hospital to be ranked as ‘high-performing’ across the board.”

Hospital rating systems are not new. They have become increasingly available to the public and replied upon by patients. Most rating systems base the results on four basic groups of data: structure, process, outcomes, and reputational scores. Reasons for the varied results across rating systems include weighting each of these groups of data differently, opposing data sources and various methodologies for processing the data within each group. Because there is no universally accepted method for measuring or reporting excellence in orthopedic surgery, each rating system is designed to support the missions of the companies that create them. Each has a unique method for data procurement and processing which results in inconsistencies across hospital rating systems.

According to Dr. Manning, with such variability between hospital rating systems, the responsibilities fall to individual institutions and physicians to report their own outcomes with transparency.

“Inconsistency among these rating systems makes it more important for us to own the conversation with our patients by providing patient commentary regarding our own performance and our own internal quality metrics for any given procedure, rather than having the rating systems do that for us,” Dr. Manning added.

For patients seeking specific orthopedic treatment or assistance, Dr. Manning suggests caution when using ranking systems as the be-all-end-all, and shares the following tips to assessing current and future orthopedic care:

  • Don’t rely solely on rating systems
  • Look for hospital and physician self-reported quality metrics and compare to local competitors
  • Ask friends and family for personal experiences and recommendations to validate your findings
  • Refer to your general physician for advice
  • Trust your instincts

The review article notes that further research is needed regarding rating systems that assess not only orthopedic surgery programs but hospitals and providers, as well. There are many aspects of healthcare that are not addressed by these rating systems, and patients should use ratings as a jumping-off point in evaluating orthopedic specialty care.

“In the future, these rating systems can only get better,” Dr. Manning said. “I believe there is a real desire among American healthcare seekers to have quality information about where and from whom they should receive their care. Eventually, there will be an acceptable definition of what constitutes excellent healthcare quality and it will be available to patients to freely review.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”